| Flagship Minerals Limited (FLG) ORDINARY FULLY PAID |
Materials |
$84 |
$1 Million Share Placement
|
30 May 2025 10:31AM |
$0.070 |
$0.260 |
risen by
271.43%
|
|
FLG - Price-sensitive ASX Announcement
Full Release
Key Points
- Flagship Minerals Limited has raised $1 million via a share placement.
- The placement was well-supported by institutional and sophisticated investors.
- Funds will be used for exploration, development, and general working capital.
- The capital raise supports ongoing and future project advancement.
- Details of the share placement include pricing and allocation information.
- An appendix is provided regarding the issue of new securities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Munro Concentrated Global Growth Fund (Managed Fund) (MCGG) |
Financials |
$109 |
Monthly Portfolio Holdings - April 2025
|
30 May 2025 10:31AM |
$16.350 |
$16.260 |
fallen by
0.55%
|
|
| Bravura Solutions Limited (BVS) ORDINARY FULLY PAID |
Information Technology |
$1,013 |
Change of Director's Interest Notice
|
30 May 2025 10:31AM |
$2.450 |
$2.260 |
fallen by
7.76%
|
|
| Askari Metals Limited (AS2) ORDINARY FULLY PAID |
Materials |
$7 |
Results of AS2O Priority Offer Entitlement Issue
|
30 May 2025 10:30AM |
$0.008 |
$0.009 |
risen by
12.50%
|
|
AS2 - Price-sensitive ASX Announcement
Full Release
Key Points
- Askari Metals Limited completed an AS2O Priority Offer Entitlement Issue.
- Eligible shareholders were invited to subscribe for new shares and attaching options.
- The announcement summarizes the number of shares and options taken up by shareholders.
- Details on the treatment and allocation of any shortfall are provided.
- The company thanks shareholders for their participation.
- Guidance is given on the expected date for allotment and trading of the new securities.
- The process aligns with the company's ongoing capital management and funding strategies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tempest Minerals Limited (TEM) ORDINARY FULLY PAID |
Materials |
$7 |
Geochemical Sampling Extends Sanity Gold Anomalies - amended
|
30 May 2025 10:30AM |
$0.004 |
$0.006 |
risen by
50%
|
|
TEM - Price-sensitive ASX Announcement
Full Release
Key Points
- Tempest Minerals Limited (TEM) provided an update on geochemical sampling at the Sanity Prospect, Meleya Project.
- Recent soil sampling identified and extended significant gold-in-soil anomalies.
- Anomalies coincide with major geological structures interpreted to be prospective for gold mineralization.
- The anomalies have increased in size compared to previously identified zones, highlighting the potential for substantive mineralization.
- Follow-up work, including infill sampling and drilling, is planned to further test these anomalies.
- The results are considered highly encouraging for the ongoing exploration program and target generation at Sanity.
- The company reiterates the strategic importance of the Meleya Project within its broader portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Munro Climate Change Leaders Fund (Managed Fund) (MCCL) |
Financials |
$219 |
Monthly Portfolio Holdings - April 2025
|
30 May 2025 10:29AM |
$18.310 |
$21.290 |
risen by
16.28%
|
|
| OzAurum Resources Limited (OZM) ORDINARY FULLY PAID |
Materials |
$27 |
Gold Mineralisation Extended at Cross Fault
|
30 May 2025 10:28AM |
$0.080 |
$0.094 |
risen by
17.50%
|
|
OZM - Price-sensitive ASX Announcement
Full Release
Key Points
- OzAurum Resources Limited reported the extension of gold mineralisation at the Cross Fault prospect.
- The Cross Fault is part of the Mulgabbie North Project in Western Australia.
- Recent drilling results have confirmed significant gold intercepts at the prospect.
- The mineralisation zone has been extended both along strike and at depth.
- High-grade gold continuity has been demonstrated along the Cross Fault structure.
- The company plans further step-out and infill drilling to delineate the resource.
- Exploration results support the potential for a substantial gold resource.
- The update underscores the company’s strategy of systematic exploration and resource growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Munro Global Growth Fund (MAET) |
Financials |
$390 |
Monthly Portfolio Holdings - April 2025
|
30 May 2025 10:28AM |
$6.880 |
$6.820 |
fallen by
0.87%
|
|
| Juno Minerals Limited (JNO) ORDINARY FULLY PAID |
Materials |
$6 |
Board Changes
|
30 May 2025 10:28AM |
$0.025 |
$0.027 |
risen by
8%
|
|
| Australian Pacific Coal Limited (AQC) ORDINARY FULLY PAID |
Materials |
$5 |
Dartbrook Financing Update
|
30 May 2025 10:28AM |
$0.055 |
$0.007 |
fallen by
88.18%
|
|
| NAOS Small Cap Opportunities Company Limited (NSC) ORDINARY FULLY PAID |
Financials |
$48 |
Update - Dividend/Distribution - NSC
|
30 May 2025 10:27AM |
$0.295 |
$0.365 |
risen by
23.73%
|
|
| Life360 Inc (360) CDI 3:1 FOREIGN EXEMPT XNGS |
Information Technology |
$3,492 |
SEC Forms 4
|
30 May 2025 10:27AM |
$32.990 |
$19.300 |
fallen by
41.50%
|
|
| Cardiex Limited (CDX) ORDINARY FULLY PAID |
Health Care |
$20 |
CDX May Investor Presentation
|
30 May 2025 10:22AM |
$0.050 |
$0.036 |
fallen by
28%
|
|
CDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Cardiex Limited is focused on cardiovascular health technology and solutions.
- The company’s core technology includes the patented SphygmoCor and the CONNEQT Pulse device.
- CONNEQT Pulse received FDA clearance, positioning it for market launch in the US.
- Cardiex is expanding into both B2B and B2C markets, targeting clinical, wearable, and remote monitoring sectors.
- Strategic partnerships are in place with leaders in healthcare, wearables, and pharmaceutical sectors.
- Revenue streams include device sales, recurring SaaS/data revenues, and licensing/partnerships.
- The global hypertension and cardiovascular health market presents significant growth opportunities.
- Cardiex’s proprietary Arterial Stiffness Index and other biomarkers differentiate its products.
- The company leverages over 20 years of clinical leadership and intellectual property.
- Ongoing innovation and regulatory milestones support expansion into new health and wellness applications.
- Strong focus on digital health, remote patient monitoring, and integration with third-party platforms.
- Significant investment in cloud infrastructure, data analytics, and AI-driven health insights.
- Cardiex is positioned for accelerated commercial growth and value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orbminco Limited (OB1) ORDINARY FULLY PAID |
Materials |
$8 |
Geophysical Surveys commence at Bronze Fox Project
|
30 May 2025 10:21AM |
$0.002 |
$0.014 |
risen by
600%
|
|
OB1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Orbminco Limited (OB1) commenced geophysical surveys at the Bronze Fox Project.
- The geophysical program includes ground magnetics and induced polarization (IP) surveys.
- Objectives are to improve geological understanding and identify targets for further exploration.
- Data from the surveys will inform future drilling and exploration strategies.
- The surveys are part of OB1’s efforts to advance exploration and increase mineral resource potential at Bronze Fox.
- The announcement emphasizes the company’s commitment to systematic exploration and project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kincora Copper Limited (KCC) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$21 |
OB1: Geophysical Surveys commence at Bronze Fox Project
|
30 May 2025 10:21AM |
$0.035 |
$0.945 |
risen by
2,600%
|
|
KCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Kincora Copper Limited commences geophysical surveys at the Bronze Fox Project in Mongolia.
- The surveys aim to improve geological understanding and support exploration and drilling.
- Expert geophysicists are involved in planning and executing the work program.
- The project targets further copper-gold discoveries in the Southern Gobi region.
- Bronze Fox is recognized for its significant mineral resource potential.
- The announcement supports Kincora’s strategic focus on district-scale copper-gold exploration.
- Collaborative efforts are emphasized to unlock the full value of the Bronze Fox Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cardiex Limited (CDX) ORDINARY FULLY PAID |
Health Care |
$20 |
Cleansing Notice
|
30 May 2025 10:21AM |
$0.050 |
$0.036 |
fallen by
28%
|
|
| Cardiex Limited (CDX) ORDINARY FULLY PAID |
Health Care |
$20 |
Proposed issue of securities - CDX
|
30 May 2025 10:21AM |
$0.050 |
$0.036 |
fallen by
28%
|
|
| Cardiex Limited (CDX) ORDINARY FULLY PAID |
Health Care |
$20 |
Cardiex Completes Placement & Launches Entitlement Offer
|
30 May 2025 10:21AM |
$0.050 |
$0.036 |
fallen by
28%
|
|
CDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Cardiex Limited announced the completion of a strategic placement to raise AUD $2.5 million before costs.
- The placement was strongly supported by both new and existing institutional and sophisticated investors.
- Funds will be used for working capital and to support the commercial roll-out of the company’s consumer and clinical devices.
- An entitlement offer to raise up to AUD $3.5 million is being launched, allowing eligible shareholders to subscribe for new shares at the same price as the placement.
- The company’s lead product is the CONNEQT Pulse, which recently received FDA clearance.
- Proceeds will also support further development of the CONNEQT Band and other pipeline products.
- The offer price was set at $0.055 per share, with one free attaching option exercisable at $0.10 expiring 24 months from issue.
- Board and management have committed to participating in the offer.
- The entitlement offer is non-renounceable and is fully underwritten by 180 Markets Pty Ltd.
- This capital raise strengthens Cardiex’s balance sheet and supports the company’s next phase of growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$8 |
Results of EGM
|
30 May 2025 10:19AM |
$0.014 |
$0.005 |
fallen by
64.29%
|
|
| NAOS Ex-50 Opportunities Company Limited (NAC) ORDINARY FULLY PAID |
Financials |
$27 |
Update - Dividend/Distribution - NAC
|
30 May 2025 10:18AM |
$0.460 |
$0.600 |
risen by
30.43%
|
|
| Cyclopharm Limited (CYC) ORDINARY FULLY PAID |
Health Care |
$94 |
CYC 2025 AGM Presentation
|
30 May 2025 10:17AM |
$1.180 |
$0.745 |
fallen by
36.86%
|
|
| Cyclopharm Limited (CYC) ORDINARY FULLY PAID |
Health Care |
$94 |
Managing Director's Address to Shareholders
|
30 May 2025 10:16AM |
$1.180 |
$0.745 |
fallen by
36.86%
|
|
| Cyclopharm Limited (CYC) ORDINARY FULLY PAID |
Health Care |
$94 |
Chair's Address to Shareholders
|
30 May 2025 10:15AM |
$1.180 |
$0.745 |
fallen by
36.86%
|
|
| Ricegrowers Limited (SGLLV) CLASS B LIMITED-VOTING ORDINARY FULLY PAID |
Consumer Staple |
$856 |
Notice regarding digital communications
|
30 May 2025 10:13AM |
$10.950 |
$12.520 |
risen by
14.34%
|
|
| Norwest Minerals Limited (NWM) ORDINARY FULLY PAID |
Materials |
$13 |
Change of Director's Interest Notice x 6
|
30 May 2025 10:12AM |
$0.011 |
$0.012 |
risen by
9.09%
|
|